Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study

Clin Transl Med. 2021 Dec;11(12):e584. doi: 10.1002/ctm2.584.

Mu-Chen Zhang¹, Ying Fang^{1

2}, Peng-Peng Xu¹, Lei Dong³, Rong Shen¹, Yao-Hui Huang¹, Di Fu¹, Zi-Xun Yan¹, Shu Cheng¹, Xu-Feng Jiang⁴, Qi Song⁵, Yang He¹, Yan Zhao¹, Min Lu¹, Jing Ye¹, Feng Liu¹, Lin Cheng¹, Chao-Fu Wang³, Li Wang^{1

6}, Wei-Li Zhao^{1

6}

¹ Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
³ Department of Pathology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Department of Nuclear Medicine, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁵ Department of Radiology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁶ Laboratory of Molecular Pathology, Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Shanghai, China.

No abstract available

Publication types